Home
  >  
Section 33

EurekaMag PDF full texts Chapter 32,844


References:

Kamal, K.S.; Parton, L.A. 1993: Plasminogen activator and plasminogen activator inhibitor are present in the bronchoalveolar lavage fluid of preterm neonates with hyaline membrane disease. Pediatric Research 33(4 Part 2): 345A
Quax, P.H.A.; Van Den Hoogen, C.M.; Verheijen, J.H.; Padro, T.; Van Berkel, T.J.C.; Zehab, R.; Gelehrter, T.D.; Kuiper, J.; Emeis, J.J. 1990: Plasminogen activator and plasminogen activator inhibitor type 1 messenger rna in rat tissues in vivo effect of endotoxin induction. Fibrinolysis 4(Suppl 3): 175
Kalderon, N. 1990: Plasminogen activator and schwann cell plasticity in peripheral nerve regeneration. Society for Neuroscience Abstracts 16(2): 1158
Brdar, B.; Matulic, M. 1990: Plasminogen activator associated with deficient dna repair. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 145
Hajjar, K.A.; Hamel, N.M. 1989: Plasminogen activator binding sites on cultured endothelial cells. Clinical Research 37(2): 546A
Reith, A.; Milne, G.; Rucklidge, G.J. 1991: Plasminogen activator can also act as an activator of glioma cell secreted metalloproteinase. European Journal of Cancer 27(Suppl 3): S36
Suzuki, T.; Kawamura, S.; Toriyama, M.; Yokokawa, Y.; Kawamoto, Y.; Hakamatsuka, Y.; Irie, H. 1996: Plasminogen activator covalently bonded to a porous body of beta-tricalcium phosphate. Official Gazette of the United States Patent and Trademark Office Patents 1183(2): 836
Leonardsson, G.; Ny, A.; Peng, X.R.; Liu, K.; Nordstrom, L.; Carmeliet, P.; Collen, D.; Ny, T. 1996: Plasminogen activator deficient mice reveal that plasmin is abundant in the ovary prior to ovulation and required for efficient physiological ovulation. Fibrinolysis 10(Suppl 3): 116
Rifkin, D.B. 1992: Plasminogen activator expression and matrix degradation. Matrix . Suppl 1: 20-22
Podorolskaya, L.V.; Andreenko, G.V.; Shelkovina, D.V. 1990: Plasminogen activator in experimental renal hypertension. Fibrinolysis 4(Suppl 1): 109
Gorewit, R.C.; Politis, I.; Barbano, D.M. 1992: Plasminogen activator in lactation and involution. FASEB Journal 6(4): A1184
Cohen, R.L.; Watanabe, K.; Schmid, J.; Brown, J.M.; Chambers, D.A. 1992: Plasminogen activator in periodontal health and disease. Annals of the new York Academy of Sciences 667: 183-185
Cohen, R.L.; Watanabe, K.; Schmid, J.; Brown, J.M.; Chambers, D.A. 1990: Plasminogen activator in periodontal homeostasis. Fibrinolysis 4(Suppl 3): 125
Seeds, N.W.; Verrall, S.; Mcguire, P.; Friedman, G. 1990: Plasminogen activator in the developing nervous system. Festoff, B W (Ed ) Nato Asi (Advanced Science Institutes) Series Series A Life Sciences, Vol 191 Serine Proteases And Their Serpin Inhibitors in The Nervous System: Regulation in Development And in Degenerative And Malignant Disease; Workshop, Maratea, Italy, July 2-8, 1989 Xxv+359p Plenum Publishing Corp : New York, New York, Usa; London, England, Uk Illus 173-184
Balboni, G.C.; Barni, T.; Forti, G.; Vannelli, G.B. 1991: Plasminogen activator in the human testis an immunohistochemical study. Abbate, R , T Barni And A Tsafriri (Ed ) Serono Symposia Publications From Raven Press, Vol 77 Plasminogen Activators: From Cloning to Therapy; International Symposium, Florence, Italy, October 29-31, 1990 Xii+204p Raven Press: New York, New York, Usa Illus 95-104
Montaser, A.H.A.J.; Neilly, I.J.; Booth, N.A.; Bennett, B. 1994: Plasminogen activator inhibitor , tissue plasminogen activator and alpha-2-antiplasmin levels in neutropenic and nonneutropenic patients with major septicaemias. British Journal of Haematology 86(Suppl 1): 12
Andreotti, F.; Hackett, D.R.; Roncaglioni, M.C.; Haider, A.W.; Davies, G.J.; Khan, M.I.; Regan, T.; Kluft, C.; Maseri, A. 1990: Plasminogen activator inhibitor 1 a novel biochemical marker of coronary reperfusion. Journal of the American College of Cardiology 15(2 Suppl A): 221A
Juhan-Vague, I.; Alessi, M.C. 1993: Plasminogen activator inhibitor 1 and atherothrombosis. Thrombosis and Haemostasis 70(1): 138-143
Kruithof, E.K.O. 1990: Plasminogen activator inhibitor 1 and its relation to thrombosis. Fibrinolysis 4(Suppl 1): 48
Rojas, F.; Hodson, D.I.; De Nardi, F.; Podor, T.; Lukka, H.; Johanson, C.; Whitton, A. 1995: Plasminogen activator inhibitor 1 and vitronectin are possible mediators of tissular radiation injury. Clinical and Investigative Medicine 18(4 Suppl): B124
Rapold, H.J.; Grimaudo, V.; Kruithof, E.K.O.; Bachmann, F. 1990: Plasminogen activator inhibitor 1 antigen levels in acute myocardial infarction before during and after treatment with tissue type plasminogen activator. European Heart Journal 11(ABSTR Suppl): 146
Lalic, K.; Djordjevic, P.B.; Lalic, N.M.; Zamaklar, M.; Dimitrijevic, V.; Jotic, A.; Ilic, M.; Rajkovic, N.; Lukic, L. 1998: Plasminogen activator inhibitor 1 daytime pattern and insulinemia in type 2 diabetes with coronary heart disease. Diabetologia 41(Suppl 1): A342
Konkle, B.A.; Schick, P.K. 1990: Plasminogen activator inhibitor 1 expression in megakaryocytes and platelets. Circulation 82(4 Suppl 3): III600
Brogren, H.én.; Wallmark, K.; Jern, S.; Karlsson, L. 2008: Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism. Thrombosis Research 121(6): 793-797
Alessi, M.C.; Chomiki, N.; Fossat, C.; Berthier, R.; Juhan Vague, I. 1994: Plasminogen activator inhibitor 1 gene expression in human megacaryocytes. Fibrinolysis 8(Suppl 1): 28
Rallidis, L.; Megalou, A.; Papageorgakis, N.; Pyrros, J.; Chatzidimitriou, G.; Tsitouris, G. 1995: Plasminogen activator inhibitor 1 is elevated in the offspring of young coronary patients. European Heart Journal 16(ABSTR Suppl ): 21
Mayer Jaekel, R.E.; Feindler Boeckh, S.; Bade, E.G. 1996: Plasminogen activator inhibitor 1 is induced by cytoskeleton reorganization in rat liver epithelial cells. European Journal of Cell Biology 69(Suppl 42): 51
Ibbotson, S.H.; Layton, A.M.; Davies, J.A.; Goodfield, M.J.D. 1994: Plasminogen activator inhibitor 1 levels in patients with chronic venous leg ulceration. British Journal of Dermatology 131(5): 738
Kluft, C. 1991: Plasminogen activator inhibitor 1 pai 1 and fibrinolysis inhibitor or marker?. Abbate, R , T Barni And A Tsafriri (Ed ) Serono Symposia Publications From Raven Press, Vol 77 Plasminogen Activators: From Cloning to Therapy; International Symposium, Florence, Italy, October 29-31, 1990 Xii+204p Raven Press: New York, New York, Usa Illus 173-184
Juhan Vague, I.; Alessi, M.C.; Vague, P. 1990: Plasminogen activator inhibitor 1 pai 1 and insulin resistance. Fibrinolysis 4(Suppl 1): 36
Hagege, J.; Rondeau, E.; Delarue, F.; Lacave, R.; Medcalf, R.; Sraer J D. 1990: Plasminogen activator inhibitor 1 pai 1 is a component of the extracellular matrix ecm of human mesangial cells hmc. Kidney International 37(1): 219
Bergstein, J.M.; Bang, N.U. 1990: Plasminogen activator inhibitor 1 pai 1 is the circulating inhibitor of fibrinolysis pai hus in the hemolytic uremic syndrome hus. Pediatric Research 27(4 Part 2): 324A
Konkle, B.A.; Schuster, S.; Kelly, M.; Hassett, D. 1990: Plasminogen activator inhibitor 1 pai 1 messenger rna expression in freshly isolated rat liver cells. Fibrinolysis 4(Suppl 3): 12
Hufnagl, P.; Gruber, F.; Lucerna, M.; Hofer, E.; Binder, B.R. 1998: Plasminogen activator inhibitor 1 promoter Analysis of responsive elements with respect to promoter polymorphism. Fibrinolysis and Proteolysis 12(Suppl 1): 38
Scherrer, A.; Kruithof, E.K.O.; Grob, J.P. 1990: Plasminogen activator inhibitor 2 a new plasma and cell marker for leukemias with a monocytic component. Fibrinolysis 4(Suppl 3): 83
Scherrer, A.; Kruithof, E.K.O.; Grob, J.P. 1990: Plasminogen activator inhibitor 2 a new plasma and cellular marker for leukemias with a monocytic component. Fibrinolysis 4(Suppl 1): 52
Risse, B.C.; Brown, H.; Pearson, J.M.; Ginsburg, D.; Lavker, R.M.; Jensen, P.J. 1998: Plasminogen activator inhibitor 2 expression in mouse epidermis and stratified epithelia. Journal of Dermatological Science 16(Suppl 1): S78
Risse, B.C.; Brown, H.; Pearson, J.M.; Ginsburg, D.; Lavker, R.M.; Jensen, P.J. 1998: Plasminogen activator inhibitor 2 expression in the mouse epidermis and stratified epithelia. Journal of Investigative Dermatology 110(4): 550
Ritchie, H.; Robbie, A.L.; Kinghorn, S.; Exley, R.; Booth, N.A. 1998: Plasminogen activator inhibitor 2 is cross-linked to fibrin and efficiently inhibits u-PA-mediated fibrinolysis. Fibrinolysis and Proteolysis 12(Suppl 1): 16
Medcalf, R.; Grant, P.; Ruegg, M. 1990: Plasminogen activator inhibitor 2 messenger rna levels are induced 1500 fold in ht 1080 fibrosarcoma cells by a selective synergistic interaction between tumor necrosis factor and phorbol ester. Fibrinolysis 4(Suppl 3): 171
Salat, C.; Reinhardt, B.; Hiller, E.; Clemm, C. 1991: Plasminogen activator inhibitor 2 pai 2 no tumor marker in b hcg positive testicular cancer and malignant histiocytoma. Onkologie 14(Suppl 2): 136-137
Hofmann, R.; Buresch, M.; Robrecht, C.; Lehmer, A.; Hartung, R. 1995: Plasminogen activator inhibitor PAI-1 is a strong prognostic factor for renal cell carcinoma. Journal of Urology 153(4 Suppl): 389A
Gray, R.; Patterson, D.L.; Yudkin, J.S. 1991: Plasminogen activator inhibitor a risk factor for myocardial infarction in diabetic subjects. European Heart Journal 12(ABSTR Suppl): 355
Haire, W.D.; Harris, W.S.; Rasmussen, J. 1989: Plasminogen activator inhibitor activity does not improve during treatment of hypertriglyceridemia with either fish oil or gemfibrozil. Clinical Research 37(4): 938A
Nagi, D.K.; Mccormack, L.J.; Mohamed Ali, V.; Yudkin, J.S.; Grant, P.J.; Knowler, W.C. 1996: Plasminogen activator inhibitor activity, its promoter genotype and diabetic retinopathy in subjects with NIDDM. Diabetologia 39(Suppl 1): A26
Gratsiansky, N.; Zateyshchikov, D.; Dobrovolsky, A.; Metelskaya, V.; Panchenko, E.; Storodgilova, A.; Tscherbakova, I. 1989: Plasminogen activator inhibitor and protein c correlate with plasma high density lipoprotein cholesterol and apoprotein b mainly in early stage of coronary artery disease. European Heart Journal 10(ABSTR Suppl): 53
Brown, N.J.; Gainer, J.V.; Nadeau, J.H.; Vaughan, D.E. 1995: Plasminogen activator inhibitor antigen is increased in hypertensive African Americans with the ACE D allele. Circulation 92(8): I552
Rutchik, S.D.; Jarrard, D.F.; Patai, B.L.; Rukstalis, D.B. 1995: Plasminogen activator inhibitor expression in the prostate. Journal of Urology 153(4 Suppl): 380A
El Naggar, Ayman; Rizk, Amal; El Fattah, Alia Abd; Nagub, Samira; El Tobgy, Sherif; Mokhtar, Sherif 1997: Plasminogen activator inhibitor in diabetes mellitus Possible role in the pathogenesis and outcome of acute myocardial infarction. European Heart Journal 18(ABSTR Suppl ): 69
Cucuianu, M.; Lanczek, M.; Roman, S. 1993: Plasminogen activator inhibitor in obese men and obese women. Revue Roumaine de Medecine Interne 31(3): 183-192
Matsuda, T.; Morishita, E.; Jokaji, H.; Saito, M.; Kumabashiri, I.; Akakura, H.; Uotani, C.; Yamazaki, M. 1995: Plasminogen activator inhibitor in plasma and arteriosclerosis. Annals of the new York Academy of Sciences 748: 394-398
Sartori, M.T.; Randi, M.L.; Zerbinati, P.; Saggiorato, G.; Theodoridis, P.; Girolami, A.; Patrassi, G.M. 1994: Plasminogen activator inhibitor in plasma and platelets of patients with thrombocythemia. Fibrinolysis 8(Suppl 1): 131
Alford, C.T.; Bennett, B.; Booth, N.A. 1994: Plasminogen activator inhibitor in platelets and isolated megakaryocytes from normal human subjects. British Journal of Haematology 86(Suppl 1): 13
Torr-Brown, S.R.; Sobel, B.E. 1994: Plasminogen activator inhibitor is elevated in plasma and diminished in platelets in patients with diabetes mellitus. Thrombosis Research 75(4): 473-477
Campbell, K.B.; Jackson, S.M.; Jamieson, A.; Johnstone, D.; Tuffin, D.P. 1989: Plasminogen activator inhibitor levels in an arthritic rabbit model effects with the anabolic steroid stanozolol. British Journal of Pharmacology 98(Proceedings Suppl DEC): 893P
Zeigler, Z.R.; Shadduck, R.K.; Andrewsi, D.F.I.; Nath, R.; Agha, M.E. 1996: Plasminogen activator inhibitor levels post-bone marrow transplantation correlate with veno-occlusive disease. Blood 88(10 Suppl 1 Part 1-2): 414A
Nielsen, L.S.; Andreasen, P.A.; Dano, K. 1995: Plasminogen activator inhibitor monoclonal antibodies, hybridomas, monoclonal antibody production and use of the antibodies for assay of the inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1175(1): 410
Davi, G.; Violi, F.; Catalano, I.; Putignano, E.; Nicolosi, G.; Notarbartolo, A.; Barbagallo, M.; Strano, A. 1989: Plasminogen activator inhibitor pai 1 antigen and thrombin antithrombin iii tat complexes in stable angina patients. European Heart Journal 10(ABSTR Suppl): 340
Coviello, M.; Quaranta, M.; Rella, C.; Micelli, G.; Tommasi, S.; Paradiso, A.; Schittulli, F. 1990: Plasminogen activator inhibitor pai 1 in breast cancer. Breast Cancer Research and Treatment 16(2): 169
Reilly, C.F.; Broski, J.E.; Mcfall, R.M. 1989: Plasminogen activator inhibitor pai activity of smooth muscle cells smc. Circulation 80(4 Suppl 2): II643
Carvalho Braga, D.; Andrade, J.; Monteiro, M.C.; Pina Cabral, J.M.; Medina, J.L.; Hargreaves, M.P. 1990: Plasminogen activator inhibitor pai and tissue plasminogen activator tpa in incipient diabetic nephropathy. Diabetologia 33(Suppl): A52
Yedavally, S.; Hartzer, M.; Williams, G.A. 1990: Plasminogen activator inhibitor pai levels and activity in the human aqueous humor. IOVS Investigative Ophthalmology and Visual Science 31(4): 508
Martin, T.J.; Allan, E.H.; Kennedy, R.K.; Fukumoto, S.; Yee, J.A.; Gelehrter, T.D. 1990: Plasminogen activator inhibitor regulation by hormones and cytokines in osteoblasts. Calcified Tissue International 46(Suppl 2): A24
Reilly, D.M.; Andreasen, P.A.; Duch, M.; Nolan, N.; Lecander, I.; Duffy, M.J. 1992: Plasminogen activator inhibitor type 1 and 2 in human breast cancer. Biochemical Society Transactions 20(1): 88s
Estelles, A.; Gilabert, J.; Espana, F.; Andres, C.; Aznar, J. 1990: Plasminogen activator inhibitor type 1 and type 2 and plasminogen activators in amniotic fluid during normal pregnancy. Fibrinolysis 4(Suppl 1): 16
Philippe, J.; Offner, F.; Vogelaers, D.; Leroux Roels, G.; Baele, G. 1990: Plasminogen activator inhibitor type 1 antigen plasma levels compared to tumors necrosis factor alpha in vivo. Fibrinolysis 4(Suppl 1): 67
Ferno, M.; Bendahl, P.O.; Brunner, N.; Langstrom, E.; Olsson, H.; Stephens, R.; Killander, D. 1996: Plasminogen activator inhibitor type 1 as a prognostic factor in breast cancer. European Journal of Cancer 32A(Suppl 1): S20
Krishnamurti, C.; Alving, B.M. 1992: Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo. Seminars in Thrombosis and Hemostasis 18(1): 67-80
Frandsen, T.L.; Stephens, R.W.; Pedersen, A.N.; Engelholm, L.H.; Holst Hansen, C.; Brunner, N. 1998: Plasminogen activator inhibitor type 1 in cancer A potential new target for antiinvasive and antimetastatic therapy. Drugs of the Future 23(8): 873-883
D.B.er J.P.; Abbink, J.J.; Brouwer, M.C.; Meijer, C.; Roem, D.; Voorn, G.P.; Lambers, J.W.J.; Van Mourik, J.A.; Hack, C.E. 1990: Plasminogen activator inhibitor type 1 pai 1 synthesis in the human hepatoma cell line hep g2 is increased by cytokines evidence that the liver contributes to acute phase behavior of pai 1. Fibrinolysis 4(Suppl 3): 177
Alessi, M.C.; Teissier, N.; Peiretti, F.; Morange, P.; Juhan Vague, I. 1996: Plasminogen activator inhibitor type 1 production by human adipose tissue. Fibrinolysis 10(Suppl 3): 23
Payne, L.; Westrick, R.J.; Dougherty, K.; Ginsburg, D. 1998: Plasminogen activator inhibitor type 2 deficiency promotes tumor growth in murine models of malignancy. Blood 92(10 Suppl 1 Part 1-2): 474A
Ny, T.; Mikus, P. 1996: Plasminogen activator inhibitor type 2 forms intracellular polymers and has a cell-specific secretion pattern. Fibrinolysis 10(Suppl 3): 14
Pytel, B.A.; Johnson, S.E.; Baglioni, C. 1990: Plasminogen activator inhibitor type 2 is induced by tumor necrosis factor and protein kinase c activity is required for its induction. Bonavida, B And G Granger (Ed ) Tumor Necrosis Factor: Structure, Mechanism Of Action, Role in Disease And Therapy; 2nd International Conference on Tumor Necrosis Factor And Related Cytokines, Napa, California, Usa, January 15-20, 1989 X+252p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 60-66
Mikus, P.; Ny, T. 1994: Plasminogen activator inhibitor type 2 partly protects against tumor necrosis factor -mediated cytolysis. Fibrinolysis 8(Suppl 1): 121
Smith, T.J.; Ahmed, A.; Hogg, M.G.; Higgins, P.J. 1992: Plasminogen activator inhibitor type i pai 1 induction by interferon gamma in human orbital fibroblast cultures. Biophysical Journal 61(2 Part 2): A454
Parton, L.A.; Laug, W.E.; Warburton, D. 1991: Plasminogen activator inhibitor type i pai 1 produced by type ii pneumocytes favors fibrin deposition. Pediatric Research 29(4 Part 2): 375A
Huber, K. 1996: Plasminogen activator inhibitor type-1 in acute coronary syndromes. Annals of Hematology 73(Suppl 1): S46
Pyke, C.; Nielsen, B.S.; Ralfkiaer, E.; Romer, J.; Solberg, H.; Brunner, N.; Dano, K. 1995: Plasminogen activator inhibitor type-1 is expressed by stromal cells in invasive ductal mammary carcinomas. Proceedings of the American Association for Cancer Research Annual Meeting 36: 100
Junker, R.; Nabavi, D.G.; Wolff, E.; Lüdemann, P.; Nowak-Göttl, U.; Käse, M.; Bäumer, R.; Ringelstein, E.B.; Assmann, G. 1998: Plasminogen activator inhibitor-1 4G/4G-genotype is associated with cerebral sinus thrombosis in factor V Leiden carriers. Thrombosis and Haemostasis 80(4): 706-707
Mossböck, G.; Weger, M.; Faschinger, C.; Schmut, O.; Renner, W. 2008: Plasminogen activator inhibitor-1 4G/5G gene polymorphism and primary open-angle glaucoma. Molecular Vision 14: 1240-1244
Vaughan, D.E. 1998: Plasminogen activator inhibitor-1: a common denominator in cardiovascular disease. Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 46(8): 370-376
Kowal, K.; Zukowski, S.; Moniuszko, M.; Bodzenta-Łukaszyk, A. 2008: Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients. Folia Histochemica et Cytobiologica 46(2): 193-198
Mutoh, M.; Niho, N.; Komiya, M.; Takahashi, M.; Ohtsubo, R.; Nakatogawa, K.; Ueda, K.; Sugimura, T.; Wakabayashi, K. 2008: Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Carcinogenesis 29(4): 824-829
Hayoz, D.; Delacretaz, E.; Kruithof, E.K.O.; Lupu, F.; Brunner, H.R.; Waeber, B. 1994: Plasminogen activator inhibitor-1 activity and fibrinogen in treated and untreated spontaneously hypertensive rats. American Journal of Hypertension 7(4 Part 2): 76A
Byberg, L.; Siegbahn, A.; Reneland, R.; Lithell, H. 1997: Plasminogen activator inhibitor-1 activity and insulin resistance in 70-year old men. Diabetologia 40(Suppl 1): A405
Nakaya, F.; Tasaka, Y.; Matsumoto, H.; Omori, Y. 1994: Plasminogen activator inhibitor-1 and fasting plasma insulin levels in NIDDM. Sakamoto, N, Alberti, K G M M, Hotta, N International Congress Series; Pathogenesis and treatment of NIDDM and its related problems 391-394
Allikmets, K.; Parik, T.; Teesalu, R.; Zilmer, K.; Zilmer, M. 1998: Plasminogen activator inhibitor-1 and plasma von Willebrand factor in essential hypertension Associations with oxidative stress and hyperinsulinaemia. European Heart Journal 19(ABST Suppl ): 69
Mansfield, M.W.; Stickland, M.H.; Grant, P.J. 1996: Plasminogen activator inhibitor-1 concentrations and vascular risk marker s in first-degree relatives of patients with non-insulin-dependent diabetes. Fibrinolysis 10(Suppl 3): 3
Kahn, M.L.; Lee, S.W.; Dichek, D.A. 1992: Plasminogen activator inhibitor-1 expression is resistant to inhibition by antisense retroviral vectors. Circulation 86(4 Suppl 1): I737
Mansfield, M.W.; Ossei Gerning, N.; Stickland, M.H.; Wilson, J.I.; Grant, P.J. 1996: Plasminogen activator inhibitor-1 genotype and levels in relation to myocardial infarction and extent of coronary atheroma. Fibrinolysis 10(Suppl 3): 3
Beuth, W.; Kasprzak, H.A.; Osinski, P.; Kotschy, M.; Rosc, D. 1995: Plasminogen activator inhibitor-1 in cerebrospinal fluid of patients after severe head injury. Journal of Neurotrauma 12(3): 493
Zamarrón, C.; Ricoy, J.; Riveiro, A.; Gude, F. 2008: Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung 186(3): 151-156
Chen, S.-C.; Henry, D.O.; Reczek, P.R.; Wong, M.K.K. 2008: Plasminogen activator inhibitor-1 inhibits prostate tumor growth through endothelial apoptosis. Molecular Cancer Therapeutics 7(5): 1227-1236
Farb, A.; Burke, A.P.; Kolodgie, F.D.; Mannan, P.; Liang, Y.H.; Smialek, J.; Virmani, R. 1996: Plasminogen activator inhibitor-1 is a determinant of coronary thrombosis in sudden cardiac death. Journal of the American College of Cardiology 27(2 Suppl A): 108A
Neilly, I.J.; Haj, M.A.; Booth, N.A.; Bennett, B. 1994: Plasminogen activator inhibitor-1 levels in neutropenic and non-neutropenic patients with major septicaemias. Fibrinolysis 8(Suppl 1): 142
Solá, E.; Vayá, A.; España, F.; Castelló, R.; Ramón, L.A.; Hernández-Mijares, A.; Vicente, V.; Estellés, A. 2008: Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism. Thrombosis Research 122(3): 320-327
Albo, D.; Berger, D.H.; Wang, T.N.; Tuszynski, G.P. 1997: Plasminogen activator inhibitor-1 plays a role in thrombospondin-1 and transforming growth factor-beta-1-mediated tumor cell invasion. Surgical Forum 48: 790-792
Ossei Gerning, N.; Mansfield, M.W.; Stickland, M.H.; Wilson, I.J.; Grant, P.J. 1996: Plasminogen activator inhibitor-1 promoter 4G/5G genotype and levels in relation to myocardial infarction in patients undergoing coronary angiography. European Journal of Clinical Investigation 26(Suppl 1): A4
Walus, M.; Chizynski, K.; Pietrucha, T.; Golanski, J.; Szemraj, J.; Watala, C. 1998: Plasminogen activator inhibitor-1 promoter polymorphism 4G/5G and plasma PAI-1 levels in subjects with ischaemic heart disease. Fibrinolysis and Proteolysis 12(Suppl 1): 38
Maher, V.M.G.; Andreotti, F.; Kitano, Y.; Neuwirth, C.; Davis, G.; Thompson, G. 1994: Plasminogen activator inhibitor-1 removal by apheresis using dextran sulphate columns. Journal of the American College of Cardiology 1994(SPEC ISSUE): 164A
Imamura, K.; Muguruma, K.; Watanabe, Y. 1993: Plasminogen activator inhibitor-I suppressed ocular dominance plasticity in kitten visual cortex. Neuroscience Research Suppl 1993(18): S150
Andreasen, P.A.; Georg, B.; Lund, L.R.; Riccio, A.; Stacey, S.N. 1990: Plasminogen activator inhibitors: hormonally regulated serpins. Molecular and Cellular Endocrinology 68(1): 1-19
Brown, J.M.; Chambers, D.A.; Cohen, R.L. 1992: Plasminogen activator inhibitors in human gingival crevicular fluid. Journal of Dental Research 71(Special Issue): 155
Leiper, K.; Booth, N.A.; Reith, A.; Simpson, A.J.; Bennett, B. 1990: Plasminogen activator inhibitors pai 1 pai 2 and t pa pai 1 complex in liver disease. British Journal of Haematology 74(Suppl 1): 8
Ludwig, R.; Lucius, R.; Mentlein, R. 1995: Plasminogen activator is involved in neuropeptide Y degradation by cultivated microglia and neurons. Biological Chemistry Hoppe-Seyler 376(SPEC Suppl ): S36
Scher, M.G.; Aidoo, R.D.; Chung, P.K.; Clark, M.B. 1991: Plasminogen activator is regulated in peripheral nerve after injury and during regeneration. Journal of Cell Biology 115(3 Part 2): 117A
Lazarus, G.S.; Baird, J.; Belin, D.; Vassalli, J.; Jensen, P. 1990: Plasminogen activator metabolism is modulated in human epidermal disease. Fibrinolysis 4(Suppl 3): 169
Hibino, T.; Segawa, I.; Kon, S.; Horii, I. 1991: Plasminogen activator pa and pa inhibitor pai are associated with keratinocyte differentiation. Clinical Research 39(2): 487A
Arndt, A.; Nakabayashi, H.; Hart, D. 1990: Plasminogen activator pa and plasminogen activator inhibitor pai expression in the human hepatoma cell line huh 7 regulation by inflammatory mediators. FASEB Journal 4(7): A2278
Wada H.; Kumeda Y.; Ogasawara Z.; Tamaki S.; Tanigawa M.; Takagi M.; Mori Y.; Deguchi A.; Iwasaki E.; Et Al 1990: Plasminogen activator plasminogen activator inhibitor and plasminogen activator stimulator in leukemic cell homogenate with hypofibrinogenemia. Fibrinolysis 4(Suppl 3): 148
Jackson, J.A.; Zhang, P.; Bahr, J.M. 1992: Plasminogen activator production by granulosa and theca layers of the chicken follicle. Biology of Reproduction 46(Suppl 1): 90
Angelici, E.; Contini, C.; Farina, G.; Romani, R.; Serra, P.; Canipari, R. 1993: Plasminogen activator production by macrophages in immunocompromised rats with Pneumocystis carinii lung infection. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 385
Heegard, C.W.; Politis, I.; White, J.H.; Zavizion, B.; Turner, J.D. 1994: Plasminogen activator production by mammary epithelial cells cultured in vitro. Journal of Dairy Science 77(Suppl 1): 120
Angelici, E.; Contini, C.; Carfagna, P.; Servidone, F.; Romani, R.; Serra, P.; Canipari, R. 1998: Plasminogen activator production in a murine model of pneumocystis carinii pneumonia Relation to inflammatory response. European Respiratory Journal 12(Suppl 28): 148S
Yakovlev, A.E.; Serebryakova, T.N.; Andreenko, G.V.; Garibova, L.V. 1996: Plasminogen activator properties of proteinase complex of basidiomycete fungus flammulina velutipes Sing. Fibrinolysis 10(Suppl 3): 60
Hiti, A.L.; Jones, P.A.; Rideout, W.M.IIi; Laug, W.E. 1989: Plasminogen activator regulation by transforming growth factor beta in cultured normal and neoplastic human urothelium. Journal of Urology 141(4 Part 2): 317A
Schnaper, H.W.; Barnathan, E.S.; Kleinman, H.K. 1993: Plasminogen activator regulation during endothelial cell morphogenesis in vitro. Pediatric Research 33(4 Part 2): 56A
Politis, I. 1996: Plasminogen activator system: implications for mammary cell growth and involution. Journal of Dairy Science 79(6): 1097-1107
Apa, R.; Lanzone, A.; Caruso, A.; Miceli, F.; Presto, M.; Mancuso, S.; Canipari, R. 1993: Plasminogen activator system Its role and regulation in the ovary. Magness, R R , Naftolin, F Serono Symposia Publications from Raven Press; Local systems in reproduction 111-124
Vercillo, M.; Conti, L.; Moro, L.; Vercillo, G.; Mottolese, M.; Botti, C.; Cavaliere, R.; Gandolfo, G.M. 1996: Plasminogen activator system and cell kinetics in human breast cancer. International Journal of Biological Markers 11(2): 126-127
Jureidini, K.F.; Henning, P.H.; Woolven, B.L.; Harris, S.J.; Keeley, S.; Martin, A.A. 1998: Plasminogen activator type-1 and interleukin-6 in plasma of children with hemolytic uremic syndrome. Pediatric Nephrology 12(7): C179
Kozlowski, K.A.; Cullum, M.E. 1990: Plasminogen activator upa and pa inhibitor pai 2 induced in granulocytic and monocytic differentiation in human promyelocytic cell line hl 60. FASEB Journal 4(3): A661
Kramer, M.D.; Schaefer, B.; Dressler, F.; Vettel, U. 1993: Plasminogen activator-dependent plasmin generation facilitates the infiltration of human T lymphocytes into proteinaceous matrices. Immunobiology 189(1-2): 21-22
Gonsalves, R.; Blankson, S.; Sheppard, B.; Mcguinness, E.; Bonnar, J. 1994: Plasminogen activators and activator inhibitors in cervical cancer. Fibrinolysis 8(Suppl 1): 55
Lotti, T.; Battini, M.L.; Brunetti, L.; Fabbri, P.; Panconesi, E. 1989: Plasminogen activators and antiplasmin activity in atopic dermatitis. International Journal of Dermatology 28(7): 457-459
Jackson, C.L.; Reidy, M.A. 1990: Plasminogen activators and arterial smooth muscle cell migration in vivo. Fibrinolysis 4(Suppl 3): 81
Collen, D. 1991: Plasminogen activators and fibrinolysis. Abbate, R , T Barni And A Tsafriri (Ed ) Serono Symposia Publications From Raven Press, Vol 77 Plasminogen Activators: From Cloning to Therapy; International Symposium, Florence, Italy, October 29-31, 1990 Xii+204p Raven Press: New York, New York, Usa Illus 151-160
Barlati, S. 1994: Plasminogen activators and fibronectin fragments in tumour growth and signal transduction. Bulletin de l'Institut Pasteur 92(4): 269-275
Verspaget H.W.; Verheijen J.H.; De Bruin P.A.F.; Griffioen G.; Lamers C.B.H.W. 1989: Plasminogen activators and gastrointestinal neoplasms. Scandinavian Journal of Gastroenterology Suppl 24(171): 13-18
Tranque, P.; Robbins, R.; Naftolin, F. 1993: Plasminogen activators and glial cell function. Magness, R R, Naftolin, F Serono Symposia Publications from Raven Press; Local systems in reproduction 57-70
Sylvie, D.; Ragni, E.; Martin, P.M. 1992: Plasminogen activators and inhibitor expression are correlated with the cellular type and its localization in the human prostate. Urological Research 20(6): 445
Koh, S.C.L.; Anandakumar, C.; Biswas, A.; Chua, S.E.; Yuen, W.K.; Ng, B.L.; Arulkumaran, S. 1998: Plasminogen activators and inhibitors in blood of fetus with good obstetric outcome compared to normal neonates and hydrops fetalis. Fibrinolysis and Proteolysis 12(Suppl 1): 92
Lecander, I.; Larsson, B.; Jonasson, A.; Larsson, J.; Lindoff, C.; Nordengren, J.; Astedt, B. 1996: Plasminogen activators and inhibitors in the human decidua of intrauterine and ectopic pregnancies. Fibrinolysis 10(Suppl 3): 118
Koh, S.C.L.; Anandakumar, C.; Arulkumaran, S.; Yuen, R.; Chua, S.E.; Ng, B.L.; Ratnam, S.S. 1994: Plasminogen activators and inhibitors, TAT-complex and coagulation factors in amniotic fluid of 2nd trimester pregnancy and during labour. Singapore Journal of Obstetrics and Gynaecology 25(1): 142
Fritz, I.B.; Ailenberg, M. 1991: Plasminogen activators and metalloproteinases in the male reproductive system. Abbate, R , T Barni And A Tsafriri (Ed ) Serono Symposia Publications From Raven Press, Vol 77 Plasminogen Activators: From Cloning to Therapy; International Symposium, Florence, Italy, October 29-31, 1990 Xii+204p Raven Press: New York, New York, Usa Illus 67-80
Rosc, D.; Bronisz, M.; Hartka, J.; Nartowicz, E.; Michalski, A. 1998: Plasminogen activators and plasminogen activator inhibitor type 1 in hemodialysed patients with chronic renal failure. Fibrinolysis and Proteolysis 12(Suppl 1): 54
Seeds, N.W.; Verrall, S.; Friedman, G.; Hayden, S.; Gadotti, D.; Haffke, S.; Christensen, K.; Gardner, B.; McGuire, P.; Krystosek, A. 1992: Plasminogen activators and plasminogen activator inhibitors in neural development. Annals of the new York Academy of Sciences 667: 32-40
Häkel, C.; Ueda, Y.; Tsuchya, H.; Herrera, A.; Blasius, S.; Roessner, A. 1994: Plasminogen activators and their inhibitor in osteosarcomas and other bone tumors. Zentralblatt für Pathologie 140(4-5): 363-369
Hamilton, J.A.; Campbell, I.K.; Wojta, J.; Cheung, D. 1992: Plasminogen activators and their inhibitors in arthritic disease. Annals of the new York Academy of Sciences 667: 87-100
Novak, J.F.; Hayes, J.D.; Mengato, R.A.; Yanosick, T.B.; Mcmaster, J.H. 1989: Plasminogen activators and their inhibitors in normal and neoplastic osteoblastic cells. Calcified Tissue International 44(Suppl): S44
Oliver, A.; Xabier, B.; Vicente, M.; Suner, R.; Laguna, P.; Mateo, J.; Fontcuberta, J.; Vincente, J. 1994: Plasminogen activators and tissue factor contents in tissular extracts of prostatic neoplasms. Fibrinolysis 8(Suppl 1): 62
Tavian, D.; Copeta, A.; Tameni, S.; De Petro, G.; Barlati, S. 1996: Plasminogen activators and urokinase-receptor mRNAs as markers of hepatocellular carcinoma. Fibrinolysis 10(Suppl 3): 16
Shireman, P.K.; Mccarthy, W.J.; Pearce, W.H.; Kwaan, H.C. 1995: Plasminogen activators are elevated in disease aorta. Surgical Forum 46: 362-364
Verspaget, H.W.; Ganesh, S.; Sier, C.F.M.; Vloedgraven, H.J.M.; Griffioen, G.; Lamers, C.B.H.W. 1992: Plasminogen activators are of prognostic relevance in colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 33: 294
D.P.tro, G.; Copeta, A.; Barlati, S. 1994: Plasminogen activators as growth factors of human fibroblasts. Fibrinolysis 8(Suppl 1): 116
Mira Y Lopez, R.; Ossowski, L. 1991: Plasminogen activators as hormone response markers in breast cancer. Abbate, R , T Barni And A Tsafriri (Ed ) Serono Symposia Publications From Raven Press, Vol 77 Plasminogen Activators: From Cloning to Therapy; International Symposium, Florence, Italy, October 29-31, 1990 Xii+204p Raven Press: New York, New York, Usa Illus 187-194
Winters, K.J.; Eisenberg, P.R.; Santoro, S.A.; Jaffe, A.S. 1989: Plasminogen activators do not directly activate platelets or degrade adhesive surface receptors. Circulation 80(4 Suppl 2): II218
Reilly, J.M. 1996: Plasminogen activators in abdominal aortic aneurysmal disease. Annals of the new York Academy of Sciences 800: 151-156
Hantai, D.; Soria, C.; Blondet, B.; Barlovatz Meimon, G.; Rao, J.S.; Festoff, B.W. 1990: Plasminogen activators in development injury and pathology of the neuromuscular system. Festoff, B W (Ed ) Nato Asi (Advanced Science Institutes) Series Series A Life Sciences, Vol 191 Serine Proteases And Their Serpin Inhibitors in The Nervous System: Regulation in Development And in Degenerative And Malignant Disease; Workshop, Maratea, Italy, July 2-8, 1989 Xxv+359p Plenum Publishing Corp : New York, New York, Usa; London, England, Uk Illus 219-228
Littlefield, B.A. 1991: Plasminogen activators in endometrial physiology and embryo implantation: a review. Annals of the new York Academy of Sciences 622: 167-175
Lazarus, G.S.; Jensen, P.J. 1991: Plasminogen activators in epithelial biology. Seminars in Thrombosis and Hemostasis 17(3): 210-216
Ginty, A.F.; Sivayoham, N.; Birch, M.A.; Gallagher, J.A. 1993: Plasminogen activators in human bone cells. Calcified Tissue International 52(Suppl 1): S41
Keer, H.N.; Gaylis, F.D.; Wilson, M.J.; Stump, D.; Kozlowski, J.M. 1989: Plasminogen activators in human prostate cancer correlation with metastasis in an in vivo model. Journal of Urology 141(4 Part 2): 218A
Carroll, P.M.; Richards, W.G.; Darrow, A.A.; Wells, J.M.; Strickland, S. 1993: Plasminogen activators in mammalian development. FASEB Journal 7(7): A1128
Seeds, N.W.; Friedman, G.; Verrall, S.; Mcguire, P. 1991: Plasminogen activators in neural development. Journal of Cellular Biochemistry Suppl (15 Part G): 113
Barlow, Y.M.; Southam, J.C. 1989: Plasminogen activators in normal and malignant oral epithelium. Journal of Dental Research 68(Special Issue): 1000
Verspaget, H.W.; Verheijen, J.H.; de Bruin, P.A.; Griffioen, G.; Lamers, C.B. 1989: Plasminogen activators in (pre)malignant conditions of the colorectum. European Journal of Cancer and Clinical Oncology 25(3): 565-569
Teikemeier, G.; Lazarus, G.; Jensen, P.J. 1989: Plasminogen activators in serum free human keratinocyte culture characterization and modes of regulation. Clinical Research 37(2): 680A
Tsafriri, A.; Reich, R. 1991: Plasminogen activators in the preovulatory follicle role in ovulation. Abbate, R , T Barni And A Tsafriri (Ed ) Serono Symposia Publications From Raven Press, Vol 77 Plasminogen Activators: From Cloning to Therapy; International Symposium, Florence, Italy, October 29-31, 1990 Xii+204p Raven Press: New York, New York, Usa Illus 81-94
Haze, C.; Garfunkel, A.A.; Eldor, A.; Korner, G.; Kadouri, A. 1989: Plasminogen activators inhibitors in human oral fluid. Journal of Dental Research 68(Special Issue): 928
Holden, R.W. 1990: Plasminogen activators: pharmacology and therapy. Radiology 174(3 Part 2): 993-1001
Takada, A.; Takada, Y. 1989: Plasminogen activators: possible roles in cell proliferation. Dermatologica 179(Suppl 1): 77-83
Runge, M.S.; Quertermous, T.; Haber, E. 1989: Plasminogen activators. The old and the new. Circulation 79(2): 217-224
Chapman, H.A. 1997: Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Current Opinion in Cell Biology 9(5): 714-724
Lotti, T.; Benci, M. 1995: Plasminogen activators, venous leg ulcers and reepithelialization. International Journal of Dermatology 34(10): 696-699
Zaas, A.K.; Liao, G.; Chien, J.W.; Weinberg, C.; Shore, D.; Giles, S.S.; Marr, K.A.; Usuka, J.; Burch, L.H.; Perera, L.; Perfect, J.R.; Peltz, G.; Schwartz, D.A. 2008: Plasminogen alleles influence susceptibility to invasive aspergillosis. PLOS Genetics 4(6): E1000101
Plow, E.; Felez, J.; Miles, L. 1990: Plasminogen and cell surfaces. Fibrinolysis 4(Suppl 3): 73
Thorsen, S.; Bangert, K. 1997: Plasminogen and plasmin inhibitor A review of their biosynthesis, biochemistry and role in fibrinolysis. Takada, A , Collen, D , Gaffney, P J International Congress Series; Recent progress in blood coagulation and fibrinolysis 47-56
Shih, G.C.; Hajjar, K.A. 1993: Plasminogen and plasminogen activator assembly on the human endothelial cell. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 202(3): 258-264
Conard, J.; Bara, L.; Samama, M. 1990: Plasminogen assays. Fibrinolysis 4(Suppl 3): 5
O'mullane, M.; Baker, M.S. 1998: Plasminogen binding and activation during cell death. Fibrinolysis and Proteolysis 12(Suppl 1): 40
Lee, M.H.; Mankowski, M.; Mcdonagh, J. 1992: Plasminogen binding impairment to clots formed at high fibrinogen concentration High level of fibrinogen as a risk factor for thrombosis. Circulation 86(4 Suppl 1): I735
Moroz, L.A.; Chang N H.; Hervas, E.; Huerta, P.; Wong, E. 1990: Plasminogen binding lipoprotein pblp a plasma vldl related to lipoprotein a lpa. Fibrinolysis 4(Suppl 3): 77
Dudani, A.K.; Hashemi, S.; Aye, M.T.; Ganz, P.R. 1990: Plasminogen binding to human endothelial cells involvement of glycoprotein iib iiia like integrins. Fibrinolysis 4(Suppl 3): 49
Züger, M.; Biasiutti, F.D.; Furlan, M.; Mannhalter, C.; Lämmle, B. 1996: Plasminogen deficiency: an additional risk factor for thrombosis in a family with factor V R506Q mutation?. Thrombosis and Haemostasis 76(3): 475-476
Ploplis, V.A.; French, E.; Carmeliet, P.; Collen, D.; Plow, E.F. 1996: Plasminogen deficiency and the inflammatory response. Circulation 94(8): I702
Schmitz, V.; Raskopf, E.; Gonzalez-Carmona, M-Angeles.; Vogt, A.; Kornek, M.; Sauerbruch, T.; Caselmann, W.H. 2008: Plasminogen derivatives encoding kringles 1-4 and kringles 1-5 exert indirect antiangiogenic and direct antitumoral effects in experimental lung cancer. Cancer Investigation 26(5): 464-470
Nagata, K.; Nakajima, K.; Takei, N.; Kohsaka, S. 1991: Plasminogen enhances the neurite outgrowth from explant cultures of peripheral and central nervous systems the physiological role of microglia. Neuroscience Research Suppl (16): S84
Bishop, A.; Morgan, R.; Young, T.W.; Matthews, S.; Ephraim, D.; Rees, A. 1990: Plasminogen gene allelic variants apo a concentration and coronary artery disease cad. Clinical Science 79(Suppl 23): 14P
Nakajima, K.; Nagata, K.; Kohsaka, S. 1994: Plasminogen mediates an interaction between microglia and dopaminergic neurons. European Neurology 34(Suppl 3): 10-16
Becquemont L.; Nguyen G.; Peraldi M N.; He C.J.; Sraer J D.; Rondeau E. 1992: Plasminogen pg plasmin pn receptor site focalizes proteolytic activity at the surface of human glomerular visceral epithelial cells hgvec. Journal of the American Society of Nephrology 3(3): 485
Kwaan, H.C.; Ernst, R.; Keer, H.; Radosevich, J.A.; Cajot, F.J. 1991: Plasminogen plasmin system in tumor invasiveness role of plasminogen activator inhibitor type 1 pai 1. Clinical Research 39(2): 356A
Plow, E.F.; Miles, L.A. 1990: Plasminogen receptors in the mediation of pericellular proteolysis. Cell Differentiation and Development: the Official Journal of the International Society of Developmental Biologists 32(3): 293-298
Yell, J.A.; Burge, S.M.; Dean, D. 1992: Plasminogen, adhesion molecules and related proteins in cantharidin induced acantholysis. British Journal of Dermatology 127(4): 427
Ferrier, C.M.; Van Geloof, W.L.; Straatman, H.; Van Muijen, G.N.P.; Suciu, S.; Ruiter, D.J. 1997: Plasminogen-activation in melanoma An immunohistochemical study. Pathology Research and Practice 193(5-6): 341
Caballero, S.; Spoerri, P.E.; Player, D.; Bush, D.M.; Grant, M.B. 1998: Plasminogen-activator-inhibitor overexpression in retinal capillaries of mice transgenic for PAI-1 mimics changes observed in diabetic retinopathy. IOVS Investigative Ophthalmology and Visual Science 39(4): S124
Spoerri, P.E.; Ellis, E.A.; Hansen, B.C.; Robison, G.W.; Grant, M.B. 1997: Plasminogen-activator-inhibitor overexpression in type II noninsulin dependent diabetic retinopathy in monkeys. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S715
Kwaan, H.; Svoboda, K.; Goolsby, C.; Weiss, I.; Sakurai, S. 1998: Plasminogen-plasmin system in tumor apoptosis. Proceedings of the American Association for Cancer Research Annual Meeting 39: 574
Lijnen, H.R.; Van Hoef, B.; Soloway, P.; Collen, D. 1998: Plasminogen/plasmin system function in mice deficient in stromelysin-1 or in tissue inhibitor of metalloproteinases type-1. Fibrinolysis and Proteolysis 12(1): 1-8
Gorkun, O.V.; Mullin, J.L.; Ping, L.F.; Lord, S.T. 1998: Plasminolysis of Aalpha 251 fibrinogen is governed by clot structure, not by tPA dependent plasminogen activation. Blood Coagulation and Fibrinolysis 9(7): 696
Bréhélin, L.; Dufayard, J.-F.ço.; Gascuel, O. 2008: PlasmoDraft: a database of Plasmodium falciparum gene function predictions based on postgenomic data. Bmc Bioinformatics 9: 440
Balachandran, S.; Xiang, Y.C.; Schobert, C.; Thompson, G.A.; Lucas, W.J. 1997: Plasmodesmal trafficking of Cucurbita maxima and Ricinus communis phloem sap proteins. Plant Physiology (Rockville) 114(3 Suppl): 24
Van Bel, A.J.E. 1995: Plasmodesmata Essential nano-links in carbohydrate processing. Journal of Experimental Botany 46(Suppl ): 60
Lucas, W.J. 1995: Plasmodesmata: intercellular channels for macromolecular transport in plants. Current Opinion in Cell Biology 7(5): 673-680
David-Geydan, T.; Marina-Melgarejo, L. 2006: Plasmodesmata Structure and function. Acta Biologica Colombiana 11(Suppl 1): 91-96
Lůcas, W.J.; Wolf, S. 1993: Plasmodesmata: the intercellular organelles of green plants. Trends in Cell Biology 3(9): 308-315
Lucas, W.J. 1995: Plasmodesmata and macromolecular trafficking New perspectives for plant biology. Journal of Experimental Botany 46(Suppl ): 59
Kollmann, R. 1994: Plasmodesmata in cell growth and development. Biologia Plantarum 36(Suppl ): S11
Burmistrova, N.; Krasavina, M.; Ktitorova, I. 1998: Plasmodesmata permeability and symplasmic assimilate unloading. Bulgarian Journal of Plant Physiology (Special Issue): 112
Lucas, W.J. 1995: Plasmodesmata, macromolecular trafficking and the supracellular nature of plants. Journal of Cellular Biochemistry Suppl 1995(21A): 442
Evert, R.F.; Russin, W.A. 1994: Plasmodesmatal distribution and frequency in the leaf of Hordeum vulgare. American Journal of Botany 81(6 Suppl): 23
Botha, C.E.J.; Hartley, B.J.; Cross, R.H.M. 1996: Plasmodesmatal frequency in relation to short-distance transport and phloem loading in leaves of barley. Journal of Experimental Botany 47(SPEC ISSUE): 1299
Lucas, W.J.; Wolf, S. 1991: Plasmodesmatal function probed using transgenic tobacco plants. (see Book Title) Author Bonnemain, Journal L , et al (Ed ) Recent advances in phloem transport and assimilate compartmentation; Fourth International Conference on Phloem Transport and Assimilate Compartmentation, Charente, France, August 19-24, 1990 xiv+344p Ouest Editions: Nantes, France Illus ISBN 2-908261-61-8: 106-115
Ding, B.; Turgeon, R.; Parthasarathy, M.V. 1991: Plasmodesmatal substructure in cryofixed developing tobacco leaf tissue. (see Book Title) Author Bonnemain, Journal L , et al (Ed ) Recent advances in phloem transport and assimilate compartmentation; Fourth International Conference on Phloem Transport and Assimilate Compartmentation, Charente, France, August 19-24, 1990 xiv+344p Ouest Editions: Nantes, France Illus ISBN 2-908261-61-8: 317-323
Ding, B.; Turgeon, R.; Parthasarathy, M.V. 1991: Plasmodesmatal ultrastructure after cryofixation. Plant Physiology 96(1 Suppl): 40
Van Der Schoot, C. 1990: Plasmodesmatal valving and the cell cell transfer of lych. Plant Physiology 93(1 Suppl): 145
Francis, S.E.; Gluzman, I.Y.; Knickerbocker, A.; Sherman, D.R.; Russell, D.G.; Goldberg, D.E. 1993: Plasmodium aspartic hemoglobinase A vacuolar enzyme with an unusual targeting route. Molecular Biology of the Cell 4(Suppl ): 316A
Moore, B.R.; Jago, J.D.; Batty, K.T. 2008: Plasmodium berghei: parasite clearance after treatment with dihydroartemisinin in an asplenic murine malaria model. Experimental Parasitology 118(4): 458-467
Link, H.T.; Krzych, U. 1992: Plasmodium berghei circumsporozoite repeat specific t cell clone recognition of the inducing cryptic epitope vs sporozoite native antigen. Journal of Cellular Biochemistry Suppl (16 Part A): 159
Muregi, F.W.; Kino, H.; Ishih, A. 2008: Plasmodium berghei: lack of antimalarial activity of an analogue of folate precursor, 2,4-diamino-6-hydroxymethylpteridine in a mouse model. Experimental Parasitology 120(3): 286-289
Lopera-Mesa, T.M.; Kushwaha, A.; Mohmmed, A.; Chauhan, V.S. 2008: Plasmodium berghei merozoite surface protein-9: immunogenicity and protective efficacy using a homologous challenge model. Vaccine 26(10): 1335-1343
Link, H.T.; Krzych, U. 1992: Plasmodium berghei sporozoite antigens do not require processing for t cell activation. Journal of Cellular Biochemistry Suppl (16 Part D): 66
Hamers Casterman, C.; Hamers, R.; Deleersnijder, W.; Tungpradubkul, S. 1989: Plasmodium chabaudi antigens associated with the red cell membrane. Journal of Cellular Biochemistry Suppl (13 Part B): 230
Li, C.; Corraliza, I.; Langhorne, J. 1997: Plasmodium chabaudi chabaudi in IL-10 defective mice. Immunology 92(Suppl 1): 37
Martinelli,A.; Rodrigues,L.A.; Cravo,P. 2008: Plasmodium chabaudi efficacy of artemisinin+curcumin combination treatment on a clone selected for artemisinin resistance in mice. Experimental Parasitology 9(2): 304-307
Aikawa, M.; Brown, A.E.; Smith, C.D.; Tegoshi, T.; Howard, R.J.; Hasler, T.H.; Ito, Y.; Collins, W.E.; Webster, H.K. 1993: Plasmodium coatney infected rhesus monkeys A primate model for human cerebral malaria. Memorias do Instituto Oswaldo Cruz Rio de Janeiro 87(Suppl 3): 443-447, 1992
Drexler, A.L.; Vodovotz, Y.; Luckhart, S. 2008: Plasmodium development in the mosquito: biology bottlenecks and opportunities for mathematical modeling. Trends in Parasitology 24(8): 333-336
Shahabuddin, M.; Pimenta, P.; Zieler, H.; Cociancich, S. 1998: Plasmodium development in the mosquito midgut Implications in developing new malaria Transmission blocking strategies. Memorias do Instituto Oswaldo Cruz 93(Suppl 2): 33-34
Huff, C.G. 1930: Plasmodium elongatum n sp, an avian malarial organism with an elongate gametocyte. American Journal of Hygiene 11(2): 385-301
Hanspal, M.; Lu, S.C.; Chishti, A. 1998: Plasmodium falciparium-derived cysteine protease cleaves human erythrocyte ankyrin. Blood 92(10 Suppl 1 Part 1-2): 4A
Doolan, D.L.; Good, M.F. 1993: Plasmodium falciparum CS protein Prime malaria vaccine candidate Definition of the human CTL domain analysis of its variation. Memorias do Instituto Oswaldo Cruz Rio de Janeiro 87(Suppl 3): 241-247, 1992
Totino, P.Renato.Rivas.; Daniel-Ribeiro, Cáudio.Tadeu.; Corte-Real, S.; de Fátima Ferreira-da-Cruz, M. 2008: Plasmodium falciparum: erythrocytic stages die by autophagic-like cell death under drug pressure. Experimental Parasitology 118(4): 478-486
Rajesh, V.; Singamsetti, V.K.; Vidya, S.; Gowrishankar, M.; Elamaran, M.; Tripathi, J.; Radhika, N.B.; Kochar, D.; Ranjan, A.; Roy, S.K.; Das, A. 2008: Plasmodium falciparum: genetic polymorphism in apical membrane antigen-1 gene from Indian isolates. Experimental Parasitology 119(1): 144-151
Gratepanche, S.; Touati, D.; Camadro, J.M.; Jacquemont, J.; Dive, D. 1995: Plasmodium falciparum SOD as a potential drug target expression of the recombinant enzyme. European Journal of Protistology 31(4): 430
French, J.B.; Cen, Y.; Sauve, A.A. 2008: Plasmodium falciparum Sir2 is an NAD+-dependent deacetylase and an acetyllysine-dependent and acetyllysine-independent NAD+ glycohydrolase. Biochemistry 47(38): 10227-10239
Siano, J.P.; Grady, K.K.; Millet, P.; Swerlick, R.A.; Wick, T.M. 1997: Plasmodium falciparum: soluble thrombospondin increases cytoadherence of parasitized erythrocytes to human microvascular endothelium under shear flow conditions. Experimental Parasitology 87(1): 69-72
Bejon, P.A.; Webb, S.E.; Mitchell, G.H. 1995: Plasmodium falciparum Tubulin in invasion. Annals of Tropical Medicine and Parasitology 89(2): 156
Walcourt, A.; Kurantsin-Mills, J.; Adenuga, B.B.; Loyevsky, M.; Kassim, O.O.; Gordeuk, V.R. 2008: Plasmodium falciparum: Activity of artemisinin against Plasmodium falciparum cultured in sickle trait hemoglobin AS and normal hemoglobin AA red blood cells. Experimental Parasitology 120(4): 381-384
Steketee, R.W.; Wirima, J.J.; Bloland, P.B.; Chelima, B.; Mermin, J.H. 1992: Plasmodium falciparum and HIV infection in pregnant women, Malawi. American Journal of Tropical Medicine and Hygiene 47(4 Suppl): 147-148
Grouffaud, S.; van West, P.; Avrova, A.O.; Birch, P.R.J.; Whisson, S.C. 2008: Plasmodium falciparum and Hyaloperonospora parasitica effector translocation motifs are functional in Phytophthora infestans. Microbiology 154(Part 12): 3743-3751
Richards, A.L.; Ratiwayanto, S.; Nuraimi, N.; Soebianto, S.; Rubiasih, I.; Riberu, W.; Purtomo, H.; Salawati, E.; Widjaja, H.; Sandjaja, B.; Fryauff, D.J.; Richie, T.L.; Church, C.J.; Jones, T.R.; Hoffman, S.L.; Kurniawan, L. 1997: Plasmodium falciparum antigen-induced IFN-gamma and TNF levels Association with immunity to malaria among residents of a hyperendemic region of Irian Jaya. Journal of Allergy and Clinical Immunology 99(1 Part 2): S454
Fowler, V.G.Jr; Lemnge, M.M.; Irare, S.G. 1992: Plasmodium falciparum at Amani, Tanzania In vivo and in vitro response to antimalarials. Clinical Research 40(4): 788A
Dow, R.B.; Davis, D. 1989: Plasmodium falciparum clues to its presence. Australian Journal of Medical Laboratory Science 10(2): 45
Cui, L.; Miao, J.; Wang, J.; Li, Q.; Cui, L. 2008: Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter. Experimental Parasitology 120(1): 80-87
Ostera, G.; Tokumasu, F.; Oliveira, F.; Sa, J.; Furuya, T.; Teixeira, C.; Dvorak, J. 2008: Plasmodium falciparum: food vacuole localization of nitric oxide-derived species in intraerythrocytic stages of the malaria parasite. Experimental Parasitology 120(1): 29-38
Stepniewska, K.; Price, R.N.; Sutherland, C.J.; Drakeley, C.J.; von Seidlein, L.; Nosten, F.; White, N.J. 2008: Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malaria Journal 7: 249
Su,V.; King,D.; Woodrow,I.; McFadden,G.; Gleadow,R. 2008: Plasmodium falciparum growth is arrested by monoterpenes from eucalyptus oil. Flavour And Fragrance Journal: 5, 315-318
Picot, S.; Ambroise Thomas, P. 1994: Plasmodium falciparum growth is regulated by TNF-alpha and complementary macrophages products. European Cytokine Network 5(2): 183
Waller, K.L.; Kim, K.; McDonald, T.V. 2008: Plasmodium falciparum: growth response to potassium channel blocking compounds. Experimental Parasitology 120(3): 280-285
O'brien, E.; Cappadoro, M.; Kurdi Haidar, B.; Mason, P.J.; Vulliamy, T.J.; Luzzatto, L. 1994: Plasmodium falciparum has an unusually large glucose-6-phosphate dehydrogenase protein which also shows some homology to glutathione-s-transferase. British Journal of Haematology 86(Suppl 1): 41
Gupta, S.Kumar.; Jain, D.; Singh, T. 2007: Plasmodium falciparum in trephine biopsy. American Journal of Hematology 83(7): 602
Crandall, I.; Sherman, I.W. 1992: Plasmodium falciparum induced modifications of band 3 protein are involved in cytoadherence. Journal of Cellular Biochemistry Suppl (16 Part A): 156
Pollack, S. 1989: Plasmodium falciparum iron metabolism. Eaton, J W , S R Meshnick And G J Brewer (Ed ) Progress in Clinical And Biological Research, Vol 313 Malaria And The Red Cell; 2nd Workshop, Ann Arbor, Michigan, Usa, October 24, 1988 Xi+169p Alan R Liss, Inc : New York, New York, Usa Illus 151-162
Aribot, G.; Rogier, C.; Sarthou, J.L.; Balde, A.T.; Roussilhon, C.; Trape, J.F.; Druilhe, P. 1995: Plasmodium falciparum isotype-specific human response in a holo-endemic area of Senegal. Annals of Tropical Medicine and Parasitology 89(2): 153
Steketee, R.W.; Wirima, J.J.; Chelima, B.; Mermin, J.H. 1993: Plasmodium falciparum malaria and HIV infection among pregnant women in rural Malawi. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 309
Wahlgren, M.; Carlson, J.; Helmby, H. 1993: Plasmodium falciparum malaria erythrocyte rosetting is mediated by promiscuous lectin-like interactions. Journal of Cellular Biochemistry Suppl 1993(17 Part A): 378
Kitua, A.; Urassa, H.; Smith, T.; Wechsler, M.; Alonso, P.; Tanner, M.; Weiss, N. 1997: Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission. Schweizerische Medizinische Wochenschrift 127(39): 1630
Matile, H.; Pink, J.R.L. 1990: Plasmodium falciparum malaria parasite cultures and their use in immunology. Lefkovits, I And B Pernis (Ed ) Immunological Methods, Vol Iv Xxvii+338p Academic Press, Inc : San Diego, California, Usa; London, England, Uk Illus 221-234
Onifade, E.U.; Obott, E.E. 1998: Plasmodium falciparum malaria presenting as nephrotic syndrome in a Nigerian child. Pediatric Nephrology 12(7): C163
Färnert, A. 2008: Plasmodium falciparum population dynamics: only snapshots in time?. Trends in Parasitology 24(8): 340-344
Merckx, A.ïs.; Nivez, M.-P.; Bouyer, G.; Alano, P.; Langsley, G.; Deitsch, K.; Thomas, S.; Doerig, C.; Egée, S.ép. 2008: Plasmodium falciparum regulatory subunit of cAMP-dependent PKA and anion channel conductance. Plos Pathogens 4(2): E19
Howard, R.F.; Arad, O.; Reese, R.T. 1989: Plasmodium falciparum rhoptry proteins. Journal of Cellular Biochemistry Suppl (13 Part E): 138
Cooperman, B.S.; Rubin, H.; Salem, J.; Fisher, A.L. 1995: Plasmodium falciparum ribonucleotide reductase DNA. Official Gazette of the United States Patent and Trademark Office Patents 1179(3): 1798
Desowitz, R.S.; Elm, J.L. 1992: Plasmodium falciparum specific IgE, IgM antibodies in paired maternal-cord sera from East Sepik Province, Papua New Guinea. American Journal of Tropical Medicine and Hygiene 47(4 Suppl): 113-114
Beier, J.C.; Madani, A.; Vaughan, J.A.; Noden, B.H. 1991: Plasmodium falciparum sporozoite release of circumsporozoite protein in the mosquito host. American Journal of Tropical Medicine and Hygiene 45(3 Suppl): 147-148
Behr, C.; Grau, G.E.; Dat, M.H.yn Ouan; Dubois, P. 1995: Plasmodium falciparum stimulated V-gamma-9 T cells are a major source of soluble and membrane bound TNF. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 255
Souza, J.M.D. 1992: Plasmodium falciparum strain resistance to drugs new drug trials. Revista do Instituto de Medicina Tropical de Sao Paulo 34(Suppl 9): S10-S15
Ochong, E.; Bell, D.J.; Johnson, D.J.; D'Alessandro, U.; Mulenga, M.; Muangnoicharoen, S.; Van Geertruyden, J-Pierre.; Winstanley, P.A.; Bray, P.G.; Ward, S.A.; Owen, A. 2008: Plasmodium falciparum strains harboring dihydrofolate reductase with the I164L mutation are absent in Malawi and Zambia even under antifolate drug pressure. Antimicrobial Agents and ChemoTherapy 52(11): 3883-3888
Slater, A.F.G. 1992: Plasmodium falciparum the biology and chemistry of hemozoin. Journal of Cellular Biochemistry Suppl (16 Part A): 115
Robson, K.J.H.; Hall, J.R.S. 1998: Plasmodium falciparum thrombospondin-related anonymous proteins , fragments and functional derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1214(4): 4127
Roberts, D.J.; Nash, G.; Craig, A.G.; Berendt, A.R.; Marsh, K.; Newbold, C.I. 1992: Plasmodium falciparum undergoes clonal antigenic variation in vitro. Journal of Cellular Biochemistry Suppl (16 Part A): 151
Knapp, B.; Hundt, E.; Enders, B.; Kupper, H. 1995: Plasmodium falciparum vaccine comprising a recombinant histidine-rich protein-HRP-II. Official Gazette of the United States Patent and Trademark Office Patents 1171(4): 2520-2521
Mukherjee, P.; Chauhan, V.S. 2008: Plasmodium falciparum-free merozoites and infected RBCs distinctly affect soluble CD40 ligand-mediated maturation of immature monocyte-derived dendritic cells. Journal of Leukocyte Biology 84(1): 244-254
Ho, M.; Udomsangpetch, R.; Reinhardt, P.; Elliott, J.; Mceverand, R.; Kubes, P. 1996: Plasmodium falciparum-infected erythrocytes role on P-selectin. FASEB Journal 10(3): A665
Madrid,D.C.; Ting,L.M.; Waller,K.L.; Schramm,V.L.; Kim,K. 2008: Plasmodium folciparum purine nucleoside phosphorylase is critical for viability of malaria parasites. Journal of Biological Chemistry 283(51): 35899-35907
Garcia, G.E.; Wirtz, R.A.; Rosenberg, R. 1997: Plasmodium gamete activation factor Isolation and characterization from the mosquito. FASEB Journal 11(9): A1440
Manwell, R.D.; Kuntz, R.E. 1966: Plasmodium hegneri n. sp. from the European teal Anas c. crecca in Taiwan. Journal of Protozoology 13(3): 437-440
Wong, K.A.; Rodriguez, A. 2008: Plasmodium infection and endotoxic shock induce the expansion of regulatory dendritic cells. Journal of Immunology 180(2): 716-726
Murata,K.; Nii,R.; Sasaki,E.; Ishikawa,S.; Sato,Y.; Sawabe,K.; Tsuda,Y.; Matsumoto,R.; Suda,A.; Ueda,M. 2008: Plasmodium juxtanucleare infection in a captive white eared-pheasant at a Japanese zoo. Journal Of Veterinary Medical Science: 2, 203-205. Ef
Vythilingam, I.; Noorazian, Y.M.; Huat, T.C.; Jiram, A.I.; Yusri, Y.M.; Azahari, A.H.; Norparina, I.; Noorrain, A.; Lokmanhakim, S. 2008: Plasmodium knowlesi in humans, macaques and mosquitoes in peninsular Malaysia. Parasites and Vectors 1(1): 26
Vinetz, J.; Li, J.; Mccutchan, T.; Kaslow, D. 1997: Plasmodium malariae causing asymptomatic splenomegaly in a patient from Greece with persistently negative blood smears. Clinical Infectious Diseases 25(2): 460
Jelliffe, E.F.; Jelliffe, D.B. 1963: Plasmodium Malariae in Ugandan Children. I. Prevalence in Young Children in Rural Communities. American Journal of Tropical Medicine and Hygiene 12: 296-297
Ridley, R.G.; Scaife, J.G. 1996: Plasmodium merozoite rhoptries antigenic polypeptides. Official Gazette of the United States Patent and Trademark Office Patents 1189(1): 403
Lainson, R.; Paperna, I. 1996: Plasmodium neusticuri nsp , a parasite of the lizard Neusticurus bicarinatus in Amazonian Brazil. Ciencia e Cultura (Sao Paulo) 48(3): 200-203
Manwell, R.D. 1949: Plasmodium oti and P. hexamerium. Journal of Parasitology 35(6): 561
Shute, P.G. 1932: Plasmodium ovale Stephens Passage of the parasite through mosquitoes and successful transmission by their bites. Annals of Tropical Medicine and Parasitology: 139-145
Kissinger, J.C.; Collins, W.E.; Mccutchan, T. 1997: Plasmodium parasites with quartan periodicities are not closely related to each other evolutionarily. Memorias do Instituto Oswaldo Cruz 92(Suppl 1): 186
Ancelin, M.; Elabbadi, N.; Vial, H. 1994: Plasmodium phospholipid metabolism during its intraerythrocytic development. Journal of Eukaryotic Microbiology 41(1): 11A
Ménard, R.; Heussler, V.; Yuda, M.; Nussenzweig, V. 2008: Plasmodium pre-erythrocytic stages: what's new?. Trends in Parasitology 24(12): 564-569
Palinauskas,V.; Valkiunas,G.; Bolshakov,C.V.; Bensch,S. 2008: Plasmodium relictum effects on experimentally infected passerine birds. Experimental Parasitology 2008(4): 372-380
Telford, Sam, R.Jr 1995: Plasmodium spp of the flying lizard Draco volans. Systematic Parasitology 31(1): 53-60
Domingues, F.C.; Hashizume, A.T.; Laurino, J.P.; Rodrigues, M.M.; Castilho, B.A.; Soares, I.S. 1998: Plasmodium vivax MSP1 Expression of the carboxyl-terminal 19-KDA fragment in Saccharomyces cerevisiae. Memorias do Instituto Oswaldo Cruz 93(Suppl 2): 134
Genton, B.; D'Acremont, Vérie.; Rare, L.; Baea, K.; Reeder, J.C.; Alpers, M.P.; Müller, I. 2008: Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. Plos Medicine 5(6): e127
Miller, L.H.; Adams, J.H.; Kaslow, D.C.; Fang, X. 1996: Plasmodium vivax and plasmodium knowlesi duffy receptor. Official Gazette of the United States Patent and Trademark Office Patents 1188(5): 3746
Langsley, G.; Patarapotikul, J.; Handunnetti, S.; Khouri, E.; Mendis, K.N.; David, P.H. 1990: Plasmodium vivax karyotype polymorphism of field isolates. Asian Pacific Journal of Allergy and Immunology 8(1): 68
Daniel-Ribeiro,C.T.; Lacerda,M.V.G.; Oliveira-Ferreira,J. 2008: Plasmodium vivax malaria in the Brazilian Amazon some aspects of its epidemiology, clinical spectrum and naturally induced immune responses. Bulletin De La Societe De Pathologie Exotique 1(3): 243-248
Havryliuk, T.; Orjuela-Sánchez, P.; Ferreira, M.U. 2008: Plasmodium vivax: microsatellite analysis of multiple-clone infections. Experimental Parasitology 120(4): 330-336
Barnadas, C.él.; Ratsimbasoa, A.èn.; Tichit, M.; Bouchier, C.; Jahevitra, M.; Picot, S.ép.; Ménard, D. 2008: Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes. Antimicrobial Agents and ChemoTherapy 52(12): 4233-4240
Renia, L.; Grillot, D.; Salone, M.M.; Corradin, G.; Miltgen, F.; Lambert, P.H.; Del Giudice, G.; Mazier, D. 1992: Plasmodium yoelii circumsporozoite protein specific CD4 positive cell clones eliminate Plasmodium yoelii liver forms in vivo and in vitro. American Journal of Tropical Medicine and Hygiene 47(4 Suppl): 222
Carwadine, S.L.; Jehan, N.; Hurd, H. 1996: Plasmodium yoelii nigeriensis Effect of developing oocysts on egg development, fecundity and fertility of Anopheles gambiae. Annals of Tropical Medicine and Parasitology 90(4): 418-419
Sam-Yellowe, T.Y.; Banks, T.L.; Fujioka, H.; Drazba, J.A.; Yadav, S.P. 2008: Plasmodium yoelii: novel rhoptry proteins identified within the body of merozoite rhoptries in rodent Plasmodium malaria. Experimental Parasitology 120(1): 113-117
Klotz, C.; Frevert, U. 2008: Plasmodium yoelii sporozoites modulate cytokine profile and induce apoptosis in murine Kupffer cells. International Journal for Parasitology 38(14): 1639-1650
Prudhomme, J.G.; Almeida-Porada, G.; Ascensao, J.L.; Sherman, I.W. 1998: Plasmodium-falciparum-infected erythrocytes adhere to immortalized human bone marrow endothelial cells. In Vitro Cellular and Developmental Biology. Animal 34(7): 524-526
Orengo, J.M.; Evans, J.E.; Bettiol, E.; Leliwa-Sytek, A.; Day, K.; Rodriguez, A. 2008: Plasmodium-induced inflammation by uric acid. Plos Pathogens 4(3): E1000013
Sapirstein, V.S.; Terio, N.; Pfeiffer, S.; Beard, M.E. 1998: Plasmolipin expression in oligodendrocytes in vitro. Journal of Neurochemistry 70(Suppl 1): S56
Nudelman, E.; Hakomori, S I.; Leverey, S.B.; Igarashi, Y.; Sadozzi, K. 1998: Plasmolopsychosines and plasmalocerebrosides. Official Gazette of the United States Patent and Trademark Office Patents 1215(4): 4107-4108
Wang, G.Z.; Miyashita, N.T.; Tsunewaki, K. 1997: Plasmon analyses of Triticum and Aegilops PCR-single-strand conformational polymorphism analyses of organellar DNAs. Proceedings of the National Academy of Sciences of the United States of America 94(26): 14570-14577
Tsunewaki, K. 1996: Plasmon analysis as the counterpart of genome analysis. Jauhar, P P Methods of genome analysis in plants: 271-299
Huang, X.; Jain, P.K.; El-Sayed, I.H.; El-Sayed, M.A. 2008: Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers in Medical Science 23(3): 217-228
Anonymous 2008: Plasmopara halstedii. Bulletin Oepp Eppo Bulletin: 3, 343-348
Ruotoistenmaki, J.M.; Ruotoistenmaki, J.; Nyman, J.A. 1997: Plaster acting as a dosing device. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 274
Borssen, B.; Lithner, F. 1989: Plaster casts in the management of advanced diabetic foot lesions. Acta Endocrinologica Suppl 120(2): 9
Roreger, M. 1997: Plaster for the transdermal application of steroid hormones, containing dexpanthenol. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 362
Cordes, G.; Vollmer, U. 1998: Plaster for the treatment of nail mycoses. Official Gazette of the United States Patent and Trademark Office Patents 1210(3): 2500
Konno, Y.; Mitomi, M.; Sonobe, T.; Yamaguchi, S. 1989: Plaster structural assembly for iontophoresis us patent 4842577 june 27 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(4): 2411
Lamers, J.S. 1998: Plaster with a supply of a medically active substance. Official Gazette of the United States Patent and Trademark Office Patents 1209(1): 401
Faierstain, P.B. 1998: Plasterless mounting dental articulator. Official Gazette of the United States Patent and Trademark Office Patents 1207(2): 1127
Emmett, J.R. 1995: Plasti-pore implants in middle ear surgery. Otolaryngologic Clinics of North America 28(2): 265-272
Abou Hadid, A.F.; Medany, M.A.; Khalifa, H.; El Beltagy, A.S. 1993: Plastic House Climate in Relation to Different Heating Efficiencies. Egyptian Journal of Horticulture 19(2): 131-136
Salman, S.R.; Abou Hadid, A.F.; El Beltagy, M.S.; El Beltagy, A.S. 1993: Plastic House Microclimate Condition as Affected by Low Tunnel and Plastic Mulch. Egyptian Journal of Horticulture 19(2): 111-119
Wells, O.S.; Mitchell, J.R. 1995: Plastic Mulch Enhances and Conserves NO-3-N in Bell Pepper. HortScience 30(4): 882
Rudin, C.E.; Garland, J.M.; Joyner, M.V. 1998: Plastic adherent haemopoietic progenitor cells in stem cell harvests and umbilical cord blood. British Journal of Haematology 101(Suppl 1): 92
Rudin, C.; Joyner, M.V.; Garland, J.M. 1997: Plastic adherent hemopoietic progenitor cells in stem cell harvests and umbilical cord blood. Blood 90(10 Suppl 1 Pt 2): 346B-347B
Takishita, N.; Mitani, A.; Masuda, S.; Kataoka, K. 1989: Plastic alteration in the interpeduncular nucleus after ablation of cholinergic neuron. Japanese Journal of Physiology 39(Suppl): S126
Rensing B.J.; Hermans W.R.M.; Beatt K.J.; Van Den Brand M.; Suryapranata H.; De Feyter P.; Serruys P.W. 1991: Plastic and elastic changes after coronary balloon angioplasty relation to restenosis. European Heart Journal 12(ABSTR Suppl): 387
Evans, A.S. 1989: Plastic and genetic variation of physiological and life history traits in rapid cycling brassica campestris. American Journal of Botany 76(6 Suppl): 146
Stanchi,S.; Freppaz,M.; Oberto,E.; Caimi,A.; Zanini,E. 2008: Plastic and liquid limits in Alpine soils methods of measurement and relation to soil properties. The Soils Of Tomorrow: Soils Changing In A Changing World: 3-604
Roberts, B.W.; Cartwright, B. 1989: Plastic and living mulch affects crop yield soil and insects. HortScience: 111
Stoker, J.; Laméris, J.S. 1993: Plastic and metal stents for distal malignant biliary obstruction. Lancet 341(8844): 559
Lynch, J.B.; Shack, R.B.uce 1998: Plastic and reconstructive care. Adkins, R B, Jr, Scott, H W, Jr Surgical care for the elderly, Second edition 467-476
Cerullo, L. 1990: Plastic artificial eyes: overview and technique. Advances in Ophthalmic Plastic and Reconstructive Surgery 8: 25-45
Hawkins, I.F.; Caridi, J.G.; Kerns, S.R. 1995: Plastic bag delivery system for hand injection of carbon dioxide. Ajr. American Journal of Roentgenology 165(6): 1487-1489
Packett, M.J.; Niemiera, A.X.; Harris, J.R.; Walden, R.F. 1996: Plastic bed surface decreases water drainage from container-grown plants. HortScience 31(4): 659
Sumi, T.; Matsumoto, K. 1997: Plastic blow container for medical fluids. Official Gazette of the United States Patent and Trademark Office Patents 1198(4): 2413
Cairns-Bazarian, A.M.; Conway, E.E.; Yankelowitz, S. 1992: Plastic bronchitis: an unusual cause of respiratory distress in children. Pediatric Emergency Care 8(6): 335-337
Jett, J.R.; Tazelaar, H.D.; Keim, L.W.; Ingrassia, T.S. 1991: Plastic bronchitis: an old disease revisited. Mayo Clinic Proceedings 66(3): 305-311
Colloridi, V.; Roggini, M.; Formigari, R.; Ventriglia, F.; Giglioni, E. 1990: Plastic bronchitis as a rare complication of Fontan's operation. Pediatric Cardiology 11(4): 228
Adamkiewicz, T.V.; Raghuram, N.; Pettignano, R.; Gal, A.A. 1996: Plastic bronchitis in patients with sickle cell disease and acute chest syndrome. Blood 88(10 Suppl 1 Part 1-2): 15B
King, J.C.; Ronsheim, P.M.; Rubin, B.S. 1996: Plastic changes in LHRH terminals, glia and portal capillaries of the median eminence as a function of ovariectomy. Society for Neuroscience Abstracts 22(1-3): 959
Nagy, I.; Polgar, E.; Szucs, P.; Urban, L.; Wood, J.N. 1995: Plastic changes in neurokinin-1 receptor expression of spinal cord neurons in inflammatory hyperalgesia. Society for Neuroscience Abstracts 21(1-3): 95
Park, J.S.; Higashi, H.; Yoshimura, M. 1998: Plastic changes in primary afferent inputs to substantia gelatinosa during post-natal development Patch clamp study. Society for Neuroscience Abstracts 24(1-2): 385
Beagley, G.H.; Hatton, G.I. 1992: Plastic changes in rat hypothalamo-neurohypophysial neuronal-glial relations induced by restraint stress. Society for Neuroscience Abstracts 18(1-2): 871
Azcurra, J.M.; Ibarra, G.R.; Rodriguez, J.A.; Paratcha, G.C.; Wolansky, M.J. 1995: Plastic changes in rat striatal receptors after circling training during development. Journal of Neurochemistry 64(Suppl 1): S103
Sato, J.; Suzuki, S.; Iseki, T.; Kumazawa, T. 1993: Plastic changes in sympathetic modulations of nociceptor activities. Japanese Journal of Physiology 43(Suppl 2): S226
Yoshimura, M.; Okamoto, M.; Baba, H.; Shimoji, K.; Higashi, H. 1996: Plastic changes in synaptic transmission of rat dorsal horn neurons following peripheral nerve transection. Society for Neuroscience Abstracts 22(1-3): 857
Bronstein, A.M. 1992: Plastic changes in the human cervicoocular reflex. Annals of the new York Academy of Sciences 656: 708-715
Calamandrei, G.; Keverne, E.B. 1990: Plastic changes in the olfactory bulbs following the onset of maternal experience in laboratory mice role of noradrenergic mechanisms. Neuroscience Letters Suppl (39): S39
Fujita, Y. 1994: Plastic changes in ventral root elicited A-spikes induced by dorsal root stimulation in cats. Japanese Journal of Physiology 44(Suppl 1): S182
Cervero, F.; Laird, J.M.A.; Pozo, M.A. 1992: Plastic changes of spinal nociceptive neurones induced by noxious visceral stimulation in the anaesthetized cat. Journal of Physiology (Cambridge) 452: 240P
Mentis, M.J.; Alexander, G.E.; Furey, M.L.; Pietini, P.; Levine, B.; Rapoport, S.I. 1997: Plastic compensation fails only at high activation levels in mild Alzheimer disease. Neurology 48(3 Suppl 2): A339
Kessler, V.; Bacher, A. 1995: Plastic container for fruits and vegetables. Official Gazette of the United States Patent and Trademark Office Patents 1172(1): 164
Myers, M.J.; Harwick, W.J. 1989: Plastic container inspection process us patent 4858767 august 22 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(4): 2308
Patterson, N.; Barron, M.J. 1997: Plastic container recycling A pesticide industry initiative. Abstracts of Papers American Chemical Society 213(1-3): AGRO 168